[go: up one dir, main page]

CN106580303A - Method for correcting systolic pressure-related pulse wave propagation time - Google Patents

Method for correcting systolic pressure-related pulse wave propagation time Download PDF

Info

Publication number
CN106580303A
CN106580303A CN201611045054.5A CN201611045054A CN106580303A CN 106580303 A CN106580303 A CN 106580303A CN 201611045054 A CN201611045054 A CN 201611045054A CN 106580303 A CN106580303 A CN 106580303A
Authority
CN
China
Prior art keywords
toe
pulse wave
ear
correcting
equal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201611045054.5A
Other languages
Chinese (zh)
Other versions
CN106580303B (en
Inventor
陈妍
陈瑜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mailian (Chongqing) Medical Technology Co.,Ltd.
Original Assignee
Zhejiang Pulse Union Medical Equipment Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Pulse Union Medical Equipment Co Ltd filed Critical Zhejiang Pulse Union Medical Equipment Co Ltd
Priority to CN201611045054.5A priority Critical patent/CN106580303B/en
Publication of CN106580303A publication Critical patent/CN106580303A/en
Priority to PCT/CN2017/098155 priority patent/WO2018095083A1/en
Priority to JP2019541843A priority patent/JP6736110B2/en
Priority to PCT/CN2017/111799 priority patent/WO2018095291A1/en
Priority to EP17874481.9A priority patent/EP3545832B1/en
Application granted granted Critical
Publication of CN106580303B publication Critical patent/CN106580303B/en
Priority to US16/391,287 priority patent/US20190246919A1/en
Priority to US17/874,618 priority patent/US20220378307A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026Measuring blood flow
    • A61B5/0285Measuring or recording phase velocity of blood waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A61B5/7217Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise originating from a therapeutic or surgical apparatus, e.g. from a pacemaker

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Signal Processing (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

The invention belongs to the technical field of arterial blood pressure measurement and provides a method for correcting systolic pressure-related pulse wave propagation time, and the method can provide adaptive correction for the change in systolic pressure-related pulse wave propagation time due to the factors such as blood and liquid transfusion, vasoactive drugs, and surgical intervention under clinical conditions. The change in the systolic pressure-related pulse wave propagation time is corrected herein by: detecting in real time, auricular pulse wave and toe pulse wave in a same cardiac cycle, calculating the systolic pressure-related pulse wave propagation time, and extracting correcting variables according to morphological characteristics of the pulse waves to obtain a correcting matrix; the corrected propagation time is applicable to existing mathematical models to continuously measure the systolic pressure in each cardiac cycle under clinical conditions, and measuring accuracy is high.

Description

与收缩压相关的脉搏波传播时间的校正方法Correction method of pulse wave transit time related to systolic blood pressure

技术领域technical field

本发明涉及动脉血压测量技术领域,具体涉及与收缩压相关的脉搏波传输时间的校正方法。The invention relates to the technical field of arterial blood pressure measurement, in particular to a correction method for pulse wave transit time related to systolic blood pressure.

背景技术Background technique

动脉血压是反映循环系统状态、评估器官灌注的主要指标之一,是围手术期监护的重要生命体征参数。目前围术期常用的血压监测方法可以分为有创测量和无创测量。有创测量是指将专用管道置入机体的循环系统内,通过转换器将机械势能转化为电子信号后在监护设备上实时显示血压变化的技术。有创测量方法可以连续、准确地测量脉搏血压,但其可能造成的危险与伤害也不容忽视。无创测量常用的方法是袖带示波法,这种技术操作简单且精确度已得到临床认可,被广泛用于健康体检和围术期监护。但是,袖带示波法只能每隔3-5分钟间断地测量血压,无法实时跟踪动脉血压的变化。Arterial blood pressure is one of the main indicators to reflect the state of the circulatory system and evaluate organ perfusion, and is an important vital sign parameter for perioperative monitoring. At present, the commonly used blood pressure monitoring methods in the perioperative period can be divided into invasive measurement and noninvasive measurement. Invasive measurement refers to the technology of placing special pipes into the body's circulatory system, converting mechanical potential energy into electronic signals through converters, and displaying blood pressure changes in real time on monitoring equipment. Invasive measurement methods can measure pulse blood pressure continuously and accurately, but the possible dangers and injuries cannot be ignored. The common method of non-invasive measurement is the cuff oscillometric method, which is simple to operate and has been clinically recognized for its accuracy, and is widely used in health checkups and perioperative monitoring. However, the cuff oscillometric method can only measure blood pressure intermittently every 3-5 minutes, and cannot track changes in arterial blood pressure in real time.

为此,医学界提出了连续无创脉搏血压测量技术,其中利用脉搏波传播时间/速度(PTT/PWV)连续无创测量每博血压的方法逐渐成为研究的热点。该测量方法通过一个或多个光电传感器和一组心电电极同步获得容积脉搏波(PhotoPlethysmoGraphy PPG)和心电信号(ECG),利用PPG与ECG之间的时间差或两个PPG之间的时间差计算出PTT/PWV;探索PTT/PWV与血压之间的函数关系并建立数学模型,利用可测量的PTT/PWV来估算血压。很多学术论文报道了利用PTT/PWV连续无创测量每博血压的原理,例如Yan Chen,Changyun Wen,Guocai Tao,Min Bi,and Guoqi Li《A Novel Modeling Methodology of theRelationship Between Blood Pressure and Pulse Wave Velocity》;Yan Chen,Changyun Wen,Guocai Tao and Min Bi《Continuous and Noninvasive Measurement ofSystolic and Diastolic Blood Pressure by One Mathematical Model with the SameModel Parameters and Two Separate Pulse Wave Velocities》;Younhee Choi,QiaoZhang,Seokbum Ko《Noninvasive cuffless blood pressure estimation using pulsetransit time and Hilbert–Huang transform》;Zheng Y,Poon CC,Yan BP,Lau JY《PulseArrival Time Based Cuff-Less and 24-H Wearable Blood Pressure Monitoring andits Diagnostic Value in Hypertension》;Mukkamala R,Hahn JO,Inan OT,Mestha LK,Kim CS,H,Kyal S《Toward Ubiquitous Blood Pressure Monitoring via PulseTransit Time:Theory and Practice》。很多专利公开了利用PTT/PWV连续无创测量每博血压的具体实施方法或装置,例如中国专利CN101229058A、CN102811659A、CN1127939C,美国专利5865755、5857975、5649543、9364158和欧洲专利0413267等。For this reason, the medical community has proposed continuous non-invasive pulse blood pressure measurement technology, among which the continuous non-invasive measurement of stroke-per-stroke blood pressure using pulse wave travel time/velocity (PTT/PWV) has gradually become a research hotspot. This measurement method obtains the volume pulse wave (PhotoPlethysmoGraphy PPG) and the electrocardiogram signal (ECG) synchronously through one or more photoelectric sensors and a group of electrocardiographic electrodes, and uses the time difference between PPG and ECG or the time difference between two PPGs to calculate Produce PTT/PWV; explore the functional relationship between PTT/PWV and blood pressure and establish a mathematical model, and use measurable PTT/PWV to estimate blood pressure. Many academic papers have reported the principle of using PTT/PWV for continuous non-invasive measurement of stroke-per-stroke blood pressure, such as Yan Chen, Changyun Wen, Guocai Tao, Min Bi, and Guoqi Li "A Novel Modeling Methodology of the Relationship Between Blood Pressure and Pulse Wave Velocity"; Yan Chen, Changyun Wen, Guocai Tao and Min Bi《Continuous and Noninvasive Measurement of Systolic and Diastolic Blood Pressure by One Mathematical Model with the SameModel Parameters and Two Separate Pulse Wave Velocities》; Younhee Choi, QiaoZhang, Seokbum Ko《Noninvasive cuffless blood pressure using pulsetransit time and Hilbert–Huang transform"; Zheng Y, Poon CC, Yan BP, Lau JY "Pulse Arrival Time Based Cuff-Less and 24-H Wearable Blood Pressure Monitoring and its Diagnostic Value in Hypertension"; Mukkamala R, Hahn JO, Inan OT, Mestha LK, Kim CS, H, Kyal S "Toward Ubiquitous Blood Pressure Monitoring via Pulse Transit Time: Theory and Practice". Many patents disclose specific implementation methods or devices for continuous non-invasive measurement of stroke blood pressure using PTT/PWV, such as Chinese patents CN101229058A, CN102811659A, CN1127939C, US patents 5865755, 5857975, 5649543, 9364158 and European patent 0413267.

现有的利用PTT/PWV测量血压的方法和技术都需要采用传统的袖带示波法测量一个或一组血压值来进行初始校准,校准的理由是PTT/PWV与血压的相关关系是对象依赖的,即每个个体的PTT/PWV与血压之间存在确定的关系,校准的目的是确定与对象相适应的数学模型参数。Existing methods and techniques for measuring blood pressure using PTT/PWV all need to use the traditional cuff oscillometric method to measure one or a set of blood pressure values for initial calibration. The reason for the calibration is that the correlation between PTT/PWV and blood pressure is subject-dependent Yes, that is, there is a definite relationship between each individual's PTT/PWV and blood pressure, and the purpose of calibration is to determine the parameters of the mathematical model that are suitable for the subject.

然而,现有方法具有一定局限性,只能应用在循环系统没有受到外界干扰的条件下。因为只有在无干扰的条件下,对个体而言PTT与血压的关系才具有较强的规律性,才可能通过确定的函数和数学模型来描述。但在围手术期,病人的循环系统在液体治疗、药物、手术操作、温度等混杂因素的影响下,PTT会发生一系列异常变化,使用异变的PTT和固有的数学模型来估算血压会产生较大的误差。由于异变的PTT与血压的关系不再具有确定的规律性,即使通过频繁校准数学模型参数来适应PTT的异变也没有解决根本问题,无法满足临床测量对准确性和实时性的要求。However, existing methods have certain limitations and can only be applied when the circulatory system is not disturbed by the outside world. Because only under the condition of no interference, the relationship between PTT and blood pressure has a strong regularity for the individual, and it is possible to describe it through a definite function and mathematical model. However, during the perioperative period, under the influence of confounding factors such as fluid therapy, drugs, surgical operations, and temperature, the patient’s circulatory system will experience a series of abnormal changes in PTT. Using the abnormal PTT and the inherent mathematical model to estimate blood pressure will produce large error. Since the relationship between the variable PTT and blood pressure no longer has a definite regularity, even if the mathematical model parameters are frequently calibrated to adapt to the PTT variation, the fundamental problem cannot be solved, and the accuracy and real-time requirements of clinical measurement cannot be met.

发明内容Contents of the invention

针对现有技术的缺陷,本发明提供一种脉搏波传播时间PTT的校正方法,能够针对临床条件下由输血输液、血管活性药物、手术介入等原因导致的与收缩压相关的脉搏波传播时间的异变进行自适性校正,准确性高。Aiming at the defects of the prior art, the present invention provides a correction method of pulse wave transit time PTT, which can correct the pulse wave transit time related to systolic blood pressure caused by blood transfusion, vasoactive drugs, surgical intervention and other reasons under clinical conditions. The mutation is adaptively corrected, and the accuracy is high.

与收缩压相关的脉搏波传播时间的校正方法,包括以下步骤:A method for correcting pulse wave transit time related to systolic blood pressure, comprising the following steps:

S1)实时检测每个心动周期下耳朵处脉搏波并分析得到耳朵脉搏波的以下数据:耳朵脉搏波上主动脉瓣关闭点的高度hsd,耳朵脉搏波的收缩期时间ts,单位为毫秒,耳朵脉搏波的舒张期时间td,单位为毫秒,耳朵脉搏波的最大高度hmaxS1) Real-time detection of the pulse wave at the ear under each cardiac cycle and analysis to obtain the following data of the ear pulse wave: the height h sd of the aortic valve closing point on the ear pulse wave, the systolic time t s of the ear pulse wave, in milliseconds , the diastolic time t d of the ear pulse wave, in milliseconds, and the maximum height h max of the ear pulse wave;

S2)实时检测每个心动周期下脚趾处脉搏波并分析得到脚趾脉搏波的以下数据:脚趾脉搏波的收缩期时间ts-toe,单位为毫秒,脚趾脉搏波的舒张期时间td-toe,单位为毫秒,脚趾脉搏波的最大高度hmax-toe,脚趾脉搏波的起始点到波峰中点的时间tch-toe,单位为毫秒,脚趾脉搏波的起始点到波峰最高点的时间tmax-toe,单位为毫秒;所述波峰中点是指波峰处的上升沿转折点和下降沿转折点的中点;S2) Real-time detection of the pulse wave at the toe under each cardiac cycle and analysis to obtain the following data of the toe pulse wave: the systolic time t s-toe of the toe pulse wave, in milliseconds, and the diastolic time t d-toe of the toe pulse wave , the unit is milliseconds, the maximum height of the toe pulse wave h max-toe , the time t ch-toe from the start point of the toe pulse wave to the midpoint of the peak, the unit is milliseconds, the time t from the start point of the toe pulse wave to the highest point of the peak max-toe , in milliseconds; the midpoint of the peak refers to the midpoint of the turning point of the rising edge and the turning point of the falling edge at the peak;

S3)计算与收缩压相关的脉搏波传播时间Ts,所述Ts是指耳朵脉搏波上的主动脉瓣关闭点到脚趾脉搏波上的主动脉瓣关闭点的时间差;h为耳朵脉搏波或脚趾脉搏波在纵轴方向上的幅值;S3) Calculate the pulse wave propagation time T s related to systolic blood pressure, said T s refers to the time difference between the aortic valve closing point on the ear pulse wave and the aortic valve closing point on the toe pulse wave; h is the ear pulse wave Or the amplitude of the toe pulse wave in the direction of the vertical axis;

S4)利用同一个心动周期下通过步骤S1、S2获得的数据,计算得到该心动周期下校正变量;S4) Using the data obtained through steps S1 and S2 in the same cardiac cycle, to calculate and obtain the correction variable in the cardiac cycle;

S5)根据步骤S4获得的该心动周期下的校正变量,计算得到该心动周期下校正矩阵;S5) Calculate and obtain a correction matrix for the cardiac cycle according to the correction variable for the cardiac cycle obtained in step S4;

S6)连续获得多个心动周期下的校正矩阵,对通过步骤S3获得的Ts进行校正;。S6) Continuously obtain correction matrices under multiple cardiac cycles, and correct T s obtained through step S3;

优选地,所述步骤S5中的校正矩阵ai为校正变量中第i校正变量。Preferably, the correction matrix in the step S5 a i is the i-th correction variable among the correction variables.

优选地,所述步骤S6具体为:连续获取8个心动周期下的校正矩阵。校正方法为:Tsma=Tsm(1-Am);其中,Ai为第i个心动周期下的校正矩阵,Tsi为第i个心动周期下的TsPreferably, the step S6 is specifically: acquiring the correction matrix under 8 cardiac cycles continuously. The correction method is: T sma =T sm (1-A m ); where, A i is the correction matrix in the i-th cardiac cycle, and T si is the T s in the i-th cardiac cycle.

优选地,所述第校正一变量a1通过以下公式计算得到:Preferably, the first corrected variable a1 is calculated by the following formula:

若d1≤ksd-m-0≤d1-2,则a1=(d1-2-ksd-m-0)×0.50;If d 1 ≤k sd-m-0 ≤d 1-2 , then a 1 =(d 1-2 -k sd-m-0 )×0.50;

若ksd-m-0<d1,则a1=28×0.50;If k sd-m-0 <d 1 , then a 1 =28×0.50;

若ksd-m-0>d1-2,则a1=0;If k sd-m-0 >d 1-2 , then a 1 =0;

其中,d1=76~84,d1-2=104~112。in, d 1 =76-84, d 1-2 =104-112.

优选地,所述第二校正变量a2通过以下公式计算得到:Preferably, the second correction variable a2 is calculated by the following formula:

若ksd-m>(d2+(age-14)/15/100),则a2=ksd-m-(d2+(age-14)/15/100);If k sd-m >(d 2 +(age-14)/15/100), then a 2 =k sd-m -(d 2 +(age-14)/15/100);

若ksd-m≤(d2+(age-14)/15/100),则a2=0;If k sd-m ≤ (d 2 +(age-14)/15/100), then a 2 =0;

其中,若|ksd-m-0-ksd-m-ts|≥40且(ksd-m-0+ksd-m-ts)/2≥ksd-m-2,则ksd-m=2×ksd-m-2-(ksd-m-0+ksd-m-ts)/2,否则ksd-m=ksd-m-2Among them, if |k sd-m-0 -k sd-m-ts |≥40 and (k sd-m-0 +k sd-m-ts )/2≥k sd-m-2 , then k sd- m = 2×k sd-m-2 -(k sd-m-0 +k sd-m-ts )/2, otherwise k sd-m =k sd-m-2 ;

age为年龄,d2=1.17~1.27。 age is age, d 2 =1.17-1.27.

优选地,所述第三校正变量a3通过以下公式计算得到:Preferably, the third correction variable a3 is calculated by the following formula:

若c4<kd-m-a<c5,则a3=0;If c 4 <k dma <c 5 , then a 3 =0;

若ksd-m-0<d6或ksd-m-2>d7,则a3=0;If k sd-m-0 <d 6 or k sd-m-2 >d 7 , then a 3 =0;

若ksd-m-0≥d6+0.10且ksd-m-2≤d8且kd-m-a≤c4,则a3=(c4-kd-m-a)×67/100;If k sd-m-0 ≥d 6 +0.10 and k sd-m-2 ≤d 8 and k dma ≤c 4 , then a 3 =(c 4 -k dma )×67/100;

则a3=(c4-kd-m-a)×50/100;like or Then a 3 =(c 4 -k dma )×50/100;

若ksd-m-0≥d6+0.10且ksd-m-2≤d8且kd-m-a≥c5,则a3=(c5-kd-m-a)×62/100;If k sd-m-0 ≥d 6 +0.10 and k sd-m-2 ≤d 8 and k dma ≥c 5 , then a 3 =(c 5 -k dma )×62/100;

则a3=(c5-kd-m-a)×45/100;like or Then a 3 =(c 5 -k dma )×45/100;

其中,若|ksd-m-0-ksd-m-ts|≥40且(ksd-m-0+ksd-m-ts)/2≥ksd-m-2且ksd-m-ts≥d3-2,则,否则 Among them, if |k sd-m-0 -k sd-m-ts |≥40 and (k sd-m-0 +k sd-m-ts )/2≥k sd-m-2 and k sd-m -ts ≥d 3-2 , then ,otherwise

若ksd-m-ts≤d3-2,则 c4=(d4+(age-14)/8)/100,d4=23~35,c5=(d5+(age-14)/8)/100,d5=27~39,d6=0.97~1.03,d7=1.52~1.58,d8=1.42~1.48,d3-2=1.21~1.31,d3=0.02~0.14,age为年龄。If k sd-m-ts ≤d 3-2 , then like but like but c 4 =(d 4 +(age-14)/8)/100, d 4 =23-35, c 5 =(d 5 +(age-14)/8)/100, d 5 =27-39, d 6 =0.97-1.03, d 7 =1.52-1.58, d 8 =1.42-1.48, d 3-2 =1.21-1.31, d 3 =0.02-0.14, age is age.

优选地,所述第四校正变量a4通过以下公式计算得到:若ks-t-toe>0.8,则a4=ks-t-toe-0.8;Preferably, the fourth correction variable a 4 is calculated by the following formula: if k st-toe >0.8, then a 4 =k st-toe -0.8;

若ks-t-toe≤0.8,则a4=0;If k st-toe ≤0.8, then a 4 =0;

其中,若tmax-toe≥tch-toe,则否则 Among them, if t max-toe ≥ t ch-toe , then otherwise

优选地,所述第五校正变量a5通过以下公式计算得到:Preferably, the fifth correction variable a5 is calculated by the following formula:

若ks-m-toe<d9,则a5=0;If k sm-toe <d 9 , then a 5 =0;

若ks-m-toe≥d9且ks-t-toe≥0.8则a5=ks-m-toe-d9If k sm- toe ≥ d 9 and k st-toe ≥ 0.8 then a 5 =k sm-toe -d 9 ;

若ks-m-toe≥d9且ks-t-toe<0.8,则a5=(ks-m-toe-d9)/2;If k sm-toe ≥ d 9 and k st-toe <0.8, then a 5 =(k sm-toe -d 9 )/2;

其中,d9=0.67~0.73, Among them, d 9 =0.67~0.73,

优选地,所述第六校正变量a6通过以下公式计算得到:Preferably, the sixth correction variable a6 is calculated by the following formula:

若ks-m-toe-ear<1.0,则a6=0;If k sm-toe-ear <1.0, then a 6 =0;

当ks-m-toe-ear>1.08,则c6=1.08,此时,若ts>220且ksd-m-0>0.88,则a6=c6-1.0,若ts<160或ksd-m-0<0.80,则a6=(c6-1.0)×0.34,若160<ts≤220或0.80<ksd-m-0≤0.88,则a6=(c6-1.0)×0.67;When k sm-toe-ear >1.08, then c 6 =1.08, at this time, if t s >220 and k sd-m-0 >0.88, then a 6 =c 6 -1.0, if t s <160 or k sd-m-0 <0.80, then a 6 =(c 6 -1.0)×0.34, if 160<t s ≤220 or 0.80<k sd-m-0 ≤0.88, then a 6 =(c 6 -1.0) ×0.67;

当1.0≤ks-m-toe-ear≤1.08,则c6=ks-m-toe-ear-1.0,此时若ts>220且ksd-m-0>0.88,则a6=c6,若ts≤160或ksd-m-0≤0.80,则a6=c6×0.34,若160<ts≤220或0.80<ksd-m-0≤0.88,则a6=c6×0.67;When 1.0≤k sm-toe-ear ≤1.08, then c 6 =k sm-toe-ear -1.0, if t s >220 and k sd-m-0 >0.88, then a 6 =c 6 , if t s ≤160 or k sd-m-0 ≤0.80, then a 6 =c 6 ×0.34, if 160<t s ≤220 or 0.80<k sd-m-0 ≤0.88, then a 6 =c 6 ×0.67 ;

其中, in,

优选地,所述第七校正变量a7通过以下公式计算得到:Preferably, the seventh correction variable a7 is calculated by the following formula:

若kts-toe-ear<1.0,则a7=0;If k ts-toe-ear <1.0, then a 7 =0;

当kts-toe-ear>1.08,则c7=1.08,此时,若ts>220且ksd-m-0>0.88,则a7=c7-1.0,若ts<160或ksd-m-0<0.80,则a7=(c7-1.0)×0.34,若160<ts≤220或0.80<ksd-m-0≤0.88,则a7=(c7-1.0)×0.67;When k ts-toe-ear >1.08, then c 7 =1.08, at this time, if t s >220 and k sd-m-0 >0.88, then a 7 =c 7 -1.0, if t s <160 or k sd-m-0 <0.80, then a 7 =(c 7 -1.0)×0.34, if 160<t s ≤220 or 0.80<k sd-m-0 ≤0.88, then a 7 =(c 7 -1.0) ×0.67;

当1.0≤kts-toe-ear≤1.08,则c7=kts-toe-ear-1.0,此时,若ts>220并且ksd-m-0>0.88,则a7=c7,若ts≤160或ksd-m-0≤0.80,则a7=c7×0.34,若160<ts≤220或0.80<ksd-m-0≤0.88,则a7=c7×0.67;When 1.0≤k ts-toe-ear ≤1.08, then c 7 =k ts-toe-ear -1.0, at this time, if t s >220 and k sd-m-0 >0.88, then a 7 =c 7 , If t s ≤160 or k sd-m-0 ≤0.80, then a 7 =c 7 ×0.34, if 160<t s ≤220 or 0.80<k sd-m-0 ≤0.88, then a 7 =c 7 × 0.67;

其中, in,

由上述技术方案可知,本发明提供的与收缩压相关的脉搏波传播时间的校正方法,通过实时检测同一个心动周期下的耳朵脉搏波和脚趾脉搏波,计算与收缩压相关的脉搏波传播时间,并根据脉搏波的形态特征提取校正变量、获得校正矩阵,对上述脉搏波传播时间的异变进行自适性校正,校正后的传播时间可用于现有的数学模型,在临床条件下连续、准确地测量每个心动周期的收缩压。It can be seen from the above technical solution that the method for correcting the pulse wave transit time related to systolic blood pressure provided by the present invention calculates the pulse wave transit time related to systolic blood pressure by detecting the ear pulse wave and toe pulse wave in the same cardiac cycle in real time , and according to the morphological characteristics of the pulse wave, the correction variable is extracted and the correction matrix is obtained, and the above-mentioned variation of the pulse wave propagation time is adaptively corrected. The corrected propagation time can be used in the existing mathematical model, and continuous, Accurately measures systolic blood pressure every cardiac cycle.

具体实施方式detailed description

下面将对本发明技术方案的实施例进行详细的描述。以下实施例仅用于更加清楚地说明本发明的技术方案,因此只是作为示例,而不能以此来限制本发明的保护范围。Embodiments of the technical solution of the present invention will be described in detail below. The following examples are only used to illustrate the technical solution of the present invention more clearly, so they are only examples, and should not be used to limit the protection scope of the present invention.

围手术期PTT的变化可分为两类。一类变化:血压变化引起的PTT变化;二类变化:PTT和血压不同步的变化(两者的变化方向或变化量不符合常规函数规律)。例如,血容量轻度不足时PTT会增加,但由于机体自身对外周阻力的调节,血压可能变化不大;胸腹手术中使用拉钩可能严重影响PTT,但对血压的影响较小;去甲肾上腺素使小动脉强烈收缩,血压明显升高,但对全身平均的PTT影响较小。Perioperative changes in PTT can be divided into two categories. Type I changes: PTT changes caused by blood pressure changes; Type II changes: PTT and blood pressure asynchronous changes (the direction or amount of change of the two does not conform to the regular function law). For example, PTT will increase when there is mild hypovolemia, but due to the body's own regulation of peripheral resistance, blood pressure may not change much; the use of retractors in thoracoabdominal surgery may seriously affect PTT, but the impact on blood pressure is small; noradrenaline The hormone makes the arterioles strongly contract, and the blood pressure increases obviously, but it has little effect on the average PTT of the whole body.

当PTT发生一类变化时,其与血压的关系仍然能够用确定函数的来表达,可通过数学模型来估算血压的变化。而当PTT发生二类变化时,使用基于常规循环系统的数学模型来估算血压会产生较大的误差。这类误差是利用PTT测量血压的原理性误差,不能通过初始定标和定期校准数学模型参数来解决。不同个体之间PTT的差异与同一个体的PTT异变是性质不同的两类问题,需要用不同的方法来解决。为此,本发明根据脉搏波的形态变化提取多种变量来间接识别和自适应校正PTT的各种二类变化,克服上述原理性误差;可结合现有的数学模型形成具备自适应校准功能的连续无创测量血压的方法,不需要依靠常规方法如袖带示波法来反复校准。When a type of change occurs in PTT, its relationship with blood pressure can still be expressed by a definite function, and the change of blood pressure can be estimated by a mathematical model. However, when PTT changes in the second category, using a mathematical model based on the conventional circulatory system to estimate blood pressure will produce large errors. This kind of error is the principle error of using PTT to measure blood pressure, which cannot be solved by initial calibration and regular calibration of mathematical model parameters. The difference of PTT between different individuals and the variation of PTT in the same individual are two different types of problems, which need to be solved by different methods. For this reason, the present invention extracts multiple variables according to the morphological changes of the pulse wave to indirectly identify and self-adaptively correct the various second-type changes of PTT, and overcome the above-mentioned principle errors; The method of continuous non-invasive blood pressure measurement does not need to rely on conventional methods such as cuff oscillometric method for repeated calibration.

检测脉搏波的人体位置优选耳朵和脚趾,这两个部位的脉搏波可以获得大动脉和外周动脉的生理、病理信息,在传播途径中具备代表性。检测脉搏信号的传感器优选红外光电容积描记仪(PPG)。耳朵和脚趾脉搏波自身的形态变化和两种脉搏波之间形态的相对变化,对识别PTT的二类变化以及人体不同部位血压之差的变化提供了丰富的信息。本发明历时数年采集大量手术病例的有创动脉血压、耳朵和脚趾的脉搏波形以及PTT进行分析,根据两个脉搏波自身及相对的形态变化提取多种变量,研究出不同的变量与PTT不同的二类变化之间的关系,并且界定各种变量的适用范围。The human body position for detecting pulse wave is preferably ears and toes. The pulse wave of these two parts can obtain the physiological and pathological information of the aorta and peripheral arteries, and is representative in the transmission route. The sensor for detecting the pulse signal is preferably an infrared photoplethysmography (PPG). The morphological changes of the ear and toe pulse waves themselves and the relative morphological changes between the two pulse waves provide a wealth of information for identifying the second type of changes in PTT and the changes in the difference in blood pressure between different parts of the body. The present invention collects invasive arterial blood pressure, pulse waveforms of ears and toes, and PTT of a large number of surgical cases for several years for analysis, and extracts multiple variables according to the two pulse waves themselves and relative morphological changes, and studies different variables that are different from PTT. The relationship between the two types of changes, and to define the scope of application of various variables.

临床应用时,利用PPT连续测量血压的过程中,实时分析脉搏波形并提取变量,根据变量是否落入适用范围判断PTT是否发生二类变化,并根据适用变量的性质确定PTT二类变化的性质和程度,如果某个变量超出适用范围说明PTT没有发生相应的二类变化,则该变量不适用;将适用的数种变量进行融合,计算出校正量对PTT进行校正,校正后的PTT/PWV适用于现有的数学模型精确计算血压。In clinical application, in the process of continuously measuring blood pressure using PPT, real-time analysis of pulse waveform and extraction of variables, according to whether the variables fall into the applicable range to determine whether PTT has a second-type change, and according to the nature of the applicable variable to determine the nature and nature of the PTT second-type change If a variable exceeds the applicable range, indicating that there is no corresponding second-type change in PTT, the variable is not applicable; the applicable variables are fused, and the correction amount is calculated to correct the PTT. The corrected PTT/PWV is applicable Accurately calculate blood pressure based on existing mathematical models.

本发明利用有限的变量来表达脉搏波形态最主要、最基本的变化规律,并研究出这些规律与PTT之间的关系。以下所述脉搏波在平面坐标上纵坐标为幅度h,横坐标为时间t,脉搏波起始点为坐标原点。The invention utilizes limited variables to express the most important and basic changing law of the pulse wave shape, and studies the relationship between these laws and PTT. The ordinate of the pulse wave described below is the amplitude h on the plane coordinate, the abscissa is the time t, and the starting point of the pulse wave is the coordinate origin.

实施例:Example:

与收缩压相关的脉搏波传播时间的校正方法,包括以下步骤:A method for correcting pulse wave transit time related to systolic blood pressure, comprising the following steps:

S1)实时检测每个心动周期下耳朵处脉搏波并分析得到耳朵脉搏波的以下数据:耳朵脉搏波上主动脉瓣关闭点的高度hsd,即收缩期与舒张期在耳朵脉搏波上呈现的交界处高度,耳朵脉搏波的收缩期时间ts,单位为毫秒,耳朵脉搏波的舒张期时间td,单位为毫秒,耳朵脉搏波的最大高度hmaxS1) Real-time detection of the pulse wave at the ear under each cardiac cycle and analysis to obtain the following data of the ear pulse wave: the height h sd of the aortic valve closing point on the ear pulse wave, that is, the systolic and diastolic phases presented on the ear pulse wave The height of the junction, the systolic time t s of the ear pulse wave, in milliseconds, the diastolic time t d of the ear pulse wave, in milliseconds, the maximum height h max of the ear pulse wave;

S2)实时检测每个心动周期下脚趾处脉搏波并分析得到脚趾脉搏波的以下数据:脚趾脉搏波的收缩期时间ts-toe,单位为毫秒,脚趾脉搏波的舒张期时间td-toe,单位为毫秒,脚趾脉搏波的最大高度hmax-toe,脚趾脉搏波的起始点到波峰中点的时间tch-toe,单位为毫秒,脚趾脉搏波中起始点到波峰最高点的时间tmax-toe,单位为毫秒;所述波峰中点是指波峰处的上升沿转折点和下降沿转折点的中点;波峰中点的定义可参考文献YAN CHEN,CHANGYUN WEN,GUOCAI TAO,and MIN BI《Continuous and Noninvasive Measurement ofSystolic and Diastolic Blood Pressure by One Mathematical Model with the SameModel Parameters and Two Separate Pulse Wave Velocities》理解。S2) Real-time detection of the pulse wave at the toe under each cardiac cycle and analysis to obtain the following data of the toe pulse wave: the systolic time t s-toe of the toe pulse wave, in milliseconds, and the diastolic time t d-toe of the toe pulse wave , the unit is milliseconds, the maximum height h max-toe of the toe pulse wave, the time t ch-toe from the starting point of the toe pulse wave to the midpoint of the peak, the unit is milliseconds, the time t from the starting point of the toe pulse wave to the highest point of the peak max-toe , the unit is milliseconds; the midpoint of the peak refers to the midpoint of the turning point of the rising edge and the turning point of the falling edge at the peak; the definition of the midpoint of the peak can refer to the literature YAN CHEN, CHANGYUN WEN, GUOCAI TAO, and MIN BI《 Continuous and Noninvasive Measurement of Systolic and Diastolic Blood Pressure by One Mathematical Model with the SameModel Parameters and Two Separate Pulse Wave Velocities" understanding.

S3)计算与收缩压相关的脉搏波传播时间Ts,其定义可参考文献YAN CHEN,CHANGYUN WEN,GUOCAI TAO,and MIN BI《Continuous and Noninvasive Measurement ofSystolic and Diastolic Blood Pressure by One Mathematical Model with the SameModel Parameters and Two Separate Pulse Wave Velocities》理解;h为耳朵脉搏波或脚趾脉搏波在纵轴方向上的幅值;S3) Calculate the pulse wave propagation time T s related to the systolic blood pressure, its definition can refer to the literature YAN CHEN, CHANGYUN WEN, GUOCAI TAO, and MIN BI "Continuous and Noninvasive Measurement of Systolic and Diastolic Blood Pressure by One Mathematical Model with the SameModel Parameters and Two Separate Pulse Wave Velocities"understanding; h is the amplitude of the ear pulse wave or toe pulse wave in the direction of the longitudinal axis;

S4)利用同一个心动周期下通过步骤S1、S2获得的数据,计算得到该心动周期下校正变量;S4) Using the data obtained through steps S1 and S2 in the same cardiac cycle, to calculate and obtain the correction variable in the cardiac cycle;

S5)根据步骤S4获得的该心动周期下的校正变量,计算得到该心动周期下校正矩阵;S5) Calculate and obtain a correction matrix for the cardiac cycle according to the correction variable for the cardiac cycle obtained in step S4;

S6)连续获得多个心动周期下的校正矩阵,对通过步骤S3获得的Ts进行校正。S6) Continuously obtain correction matrices under multiple cardiac cycles, and correct T s obtained through step S3.

该方法能够实时检测同一个心动周期下的耳朵脉搏波和脚趾脉搏波,计算与收缩压相关的脉搏波传播时间,并根据脉搏波的形态特征提取校正变量、获得校正矩阵,对上述脉搏波传播时间的异变进行校正,校正后的传播时间可用于现有的数学模型,在临床条件下连续测量每个心动周期的收缩压。This method can detect the ear pulse wave and toe pulse wave in the same cardiac cycle in real time, calculate the pulse wave propagation time related to the systolic pressure, and extract the correction variables and obtain the correction matrix according to the pulse wave morphological characteristics, and the above pulse wave propagation Time variation is corrected, and the corrected propagation time can be used in existing mathematical models to continuously measure systolic blood pressure every cardiac cycle under clinical conditions.

第一校正变量a1First correction variable a 1 :

所述步骤S4中获得的校正变量包括第一校正变量a1,a1用于低血压状态校正与收缩压相关的传播时间Ts的二类变化,a1的适用范围为a1>0,a1越大则指示血压越低。The correction variables obtained in the step S4 include the first correction variable a 1 , a 1 is used to correct the second-type change of the propagation time T s related to the systolic blood pressure in a hypotensive state, and the applicable range of a 1 is a 1 >0, The larger a 1 is, the lower the blood pressure is indicated.

ksd-m-0表示hsd与耳朵脉搏波收缩期平均高度之比。一部分病例在低血压状态时,脉搏波波峰呈现向前倾的三角形。hsd降低很多,ksd-m-0变小,说明主动脉收缩期末段波形降低很多,推动脉搏波传播的持续动力不足,传播时间延长。在这种状态的舒张期信息不稳定,不宜使用。d1=76~84,优选为80;d1-2=104~112,优选为108。 k sd-m-0 represents the ratio of h sd to the average systolic height of the ear pulse wave. In some cases, when the blood pressure is low, the peak of the pulse wave presents a forward-leaning triangle. The h sd decreased a lot, and the k sd-m-0 became smaller, indicating that the waveform of the end-systolic period of the aorta decreased a lot, the continuous power to propel the pulse wave propagation was insufficient, and the propagation time was prolonged. Diastolic information in this state is unstable and should not be used. d 1 =76-84, preferably 80; d 1-2 =104-112, preferably 108.

当推动脉搏波传播的持续动力不足时,传播时间Ts延长,需要a1校正。即若d1≤ksd-m-0≤d1-2,则a1=(d1-2-ksd-m-0)×0.50;When the continuous power to propel the pulse wave propagation is insufficient, the propagation time T s is prolonged, requiring a 1 correction. That is, if d 1 ≤k sd-m-0 ≤d 1-2 , then a 1 =(d 1-2 -k sd-m-0 )×0.50;

当推动脉搏波传播的持续动力严重不足时,传播时间Ts延长很多,a1取上限值来校正。即若ksd-m-0<d1,则a1=28×0.50;When the continuous power to propel the pulse wave propagation is seriously insufficient, the propagation time T s is prolonged a lot, and a 1 is corrected by taking the upper limit value. That is, if k sd-m-0 <d 1 , then a 1 =28×0.50;

当推动脉搏波传播的持续动力充足时,不需要校正Ts,a1不适用。即若ksd-m-0>d1-2,则a1=0。When the continuous power to propel the pulse wave propagation is sufficient, no correction of T s is required, a 1 is not applicable. That is, if k sd-m-0 >d 1-2 , then a 1 =0.

第二校正变量a2Second correction variable a 2 :

所述步骤S4中获得的校正变量还包括第二校正变量a2,a2用于高血压状态以及从正常血压状态到高血压状态的变化过程,校正与收缩压相关的脉搏波传播时间Ts的二类变化,a2的适用范围为a2>0,a2越大则表明收缩压越高。The correction variable obtained in the step S4 also includes a second correction variable a 2 , a 2 is used for the hypertensive state and the change process from the normal blood pressure state to the hypertensive state, and corrects the pulse wave propagation time T s related to the systolic blood pressure The applicable range of a 2 is a 2 >0, and the larger the a 2 is, the higher the systolic blood pressure is.

ksd-m-ts表示hsd与耳朵脉搏波舒张期ts-2ts段平均高度之比,用于判断脉搏波舒张期的变异。例如,胸腹手术中上拉钩导致主动脉受力变化,使耳朵脉搏波舒张期的波形降低,ksd-m-ts变大。 k sd-m-ts represents the ratio of h sd to the average height of ear pulse wave diastolic period t s -2t s segment, which is used to judge the variation of pulse wave diastolic period. For example, in thoracoabdominal surgery, the upper retractor leads to changes in the force on the aorta, which reduces the diastolic waveform of the ear pulse wave and increases the k sd-m-ts .

ksd-m-2表示hsd与耳朵脉搏波0-2ts段平均高度之比,包含了收缩期和部分舒张期的波形信息,主要用于高血压状态以及从正常血压状态到高血压状态的变化过程,如气管插管导致心率和血压升高。从正常血压状态到高血压状态的变化过程中,耳朵脉搏波的波峰逐渐呈现正三角形或后倾的三角形,hsd逐渐升高,ksd-m-2逐渐变大;在高血压状态下,整个耳朵脉搏波都呈现正三角形或后倾的三角形,hsd升高很多,ksd-m-2变得很大;上述两种波形的三角形顶端(即最高血压)持续时间都非常短,与最高血压相对应的持续动力不足,传播时间Ts相对延长。 k sd-m-2 represents the ratio of h sd to the average height of the 0-2t s segment of the ear pulse wave, which contains the waveform information of the systolic and partial diastolic phases, and is mainly used for hypertensive states and from normal blood pressure states to hypertensive states Changes in the process, such as endotracheal intubation leading to increased heart rate and blood pressure. During the change from normotensive state to hypertensive state, the peak of the ear pulse wave gradually presents an equilateral triangle or a retroverted triangle, h sd gradually increases, and k sd-m-2 gradually increases; in the state of hypertension, The pulse wave of the whole ear presents an equilateral triangle or a retroverted triangle, h sd rises a lot, and k sd-m-2 becomes very large; the duration of the triangular top (namely the highest blood pressure) of the above two waveforms is very short, which is consistent with Corresponding to the continuous lack of motivation of the highest blood pressure, the transmission time T s is relatively prolonged.

若|ksd-m-0-ksd-m-ts|≥40而且(ksd-m-0+ksd-m-ts)/2≥ksd-m-2If |k sd-m-0 -k sd-m-ts |≥40 and (k sd-m-0 +k sd-m-ts )/2≥k sd-m-2 ,

则ksd-m=2×ksd-m-2-(ksd-m-0+ksd-m-ts)/2,Then k sd-m =2×k sd-m-2 -(k sd-m-0 +k sd-m-ts )/2,

否则ksd-m=ksd-m-2Otherwise k sd-m = k sd-m-2 ;

若耳朵脉搏波舒张期的波形变异,例如,胸腹手术上拉钩导致主动脉受力变化,脉搏波舒张期的形态出现显著变化,则对ksd-m进行校正,否则ksd-m=ksd-m-2。d2=1.17~1.27,优选为1.22。If the waveform of the ear pulse wave in the diastolic period varies, for example, the force change of the aorta caused by the pulling hook in the thoracic and abdominal surgery, and the shape of the pulse wave in the diastolic period changes significantly, then correct k sd- m , otherwise k sd-m = k sd-m-2 . d 2 =1.17˜1.27, preferably 1.22.

若ksd-m>(d2+(age-14)/15/100),其中age为年龄,age≥14岁,指示整个耳朵脉搏波或其波峰变为正三角形或后倾的三角形,与最高血压相对应的持续动力不足,传播时间Ts相对延长,需要a2来校正,则a2=ksd-m-(d2+(age-14)/15/100)。If k sd-m >(d 2 +(age-14)/15/100), where age is age, and age≥14 years old, it indicates that the pulse wave of the whole ear or its peak becomes a regular triangle or a backward triangle, which is consistent with The sustained lack of power corresponding to the highest blood pressure and the relatively prolonged propagation time T s require a 2 to correct, then a 2 =k sd-m -(d 2 +(age-14)/15/100).

若ksd-m≤(d2+(age-14)/15/100),脉搏波波峰部分平缓,与最高血压相对应的持续动力充足,不需要a2来校正,则令a2=0。If k sd-m ≤(d 2 +(age-14)/15/100), the peak of the pulse wave is gentle, and the continuous power corresponding to the highest blood pressure is sufficient, and a 2 is not needed for correction, then let a 2 =0 .

第三校正变量a3The third correction variable a 3 :

所述步骤S4中获得的校正变量还包括第三校正变量a3,a3用于在血容量变化或传感器安放部位体温变化的状态下对Ts进行校正。The correction variable obtained in the step S4 further includes a third correction variable a 3 , a 3 is used to correct T s when the blood volume changes or the body temperature of the sensor placement site changes.

为耳朵脉搏波舒张期平均高度与最大高度hmax之比。在手术前病人禁食且少喝水时血容量降低,减小,脉搏波传播时间延长,当手术中输血输液导致血容量增加时,增大,传播时间缩短。 It is the ratio of the average diastolic height of the ear pulse wave to the maximum height h max . When the patient fasts and drinks less water before the operation, the blood volume decreases, Decrease, pulse wave propagation time prolongs, when blood transfusion during operation leads to increased blood volume, increases, the propagation time shortens.

若ksd-m-ts≤d3-2,指示耳朵脉搏波舒张早期的波形升高且超越正常范围,需要对进行修正,修正结果记为 If k sd-m-ts ≤d 3-2 , it indicates that the wave form of the ear pulse wave in the early diastole is elevated and exceeds the normal range, and it needs to be checked Correction is carried out, and the correction result is recorded as

可判断出耳朵脉搏波受到干扰,则d3=0.02~0.14,优选为0.08;d3-2=1.21~1.31,优选为1.26。 like It can be judged that the ear pulse wave is disturbed, then d 3 =0.02-0.14, preferably 0.08; d 3-2 =1.21-1.31, preferably 1.26.

为脚趾脉搏波舒张期平均高度与最大高度hmax-toe之比,ts-toe表示脚趾脉搏波上识别的心脏收缩期时间,td-toe表示脚趾脉搏波上识别的舒张期时间。若的作用和性质相同。 is the ratio of the average diastolic height of the toe pulse wave to the maximum height h max-toe , t s-toe represents the systolic time recognized on the toe pulse wave, and t d-toe represents the diastolic time recognized on the toe pulse wave. like but and same function and nature.

将耳朵和脚趾脉搏波性质相同的两个变量合并,取其平均值作为校准Ts的变量;如果脉搏波舒张期的波形发生变异,对kd-m-a进行校正。 The two variables with the same properties of the ear and toe pulse wave are combined, and the average value is taken as the variable for calibrating T s ; if the waveform of the pulse wave in the diastolic period varies, the k dma is corrected.

若|ksd-m-0-ksd-m-ts|≥40且(ksd-m-0+ksd-m-ts)/2≥ksd-m-2且ksd-m-ts≥d3-2If |k sd-m-0 -k sd-m-ts |≥40 and (k sd-m-0 +k sd-m-ts )/2≥k sd-m-2 and k sd-m-ts ≥d 3-2 ,

but

在血容量正常而且传感器安放部位体温也正常的状态,a3不适用。即若c4<kd-m-a<c5,则令a3=0。c4=(d4+(age-14)/8)/100,d4=23~35,优选为29;c5=(d5+(age-14)/8)/100,d5=27~39,优选为33。In the state of normal blood volume and normal body temperature at the place where the sensor is placed, a 3 is not applicable. That is, if c 4 <k dma <c 5 , then set a 3 =0. c 4 =(d 4 +(age-14)/8)/100, d 4 =23-35, preferably 29; c 5 =(d 5 +(age-14)/8)/100, d 5 = 27-39, preferably 33.

在血压很低或很高的状态,舒张期信息不稳定,a3不适用。即若ksd-m-0<d6或ksd-m-2>d7,则令a3=0。d6=0.97~1.03,优选为1.00;d7=1.52~1.58,优选为1.55。In states of very low or very high blood pressure, the diastolic information is not stable, a 3 is not applicable. That is, if k sd-m-0 <d 6 or k sd-m-2 >d 7 , then set a 3 =0. d 6 =0.97-1.03, preferably 1.00; d 7 =1.52-1.58, preferably 1.55.

在正常血压状态,血容量降低或传感器安放部位体温降低时,a3取正值的67%。即若ksd-m-0≥d6+0.10而且ksd-m-2≤d8并且kd-m-a≤c4,则a3=(c4-kd-m-a)×67/100。d8=1.42~1.48,优选为1.45。In normotensive state, when the blood volume decreases or the body temperature of the place where the sensor is placed decreases, a 3 takes 67% of the positive value. That is, if k sd-m-0 ≥d 6 +0.10 and k sd-m-2 ≤d 8 and k dma ≤c 4 , then a 3 =(c 4 −k dma )×67/100. d 8 =1.42˜1.48, preferably 1.45.

在血压较低或较高的状态,血容量降低或传感器安放部位体温降低时,a3取正常血压状态数值的50%。即若则a3=(c4-kd-m-a)×50/100;In the state of low or high blood pressure, when the blood volume decreases or the body temperature of the place where the sensor is placed drops, a 3 takes 50% of the value in the state of normal blood pressure. That is if or Then a 3 =(c 4 -k dma )×50/100;

在正常血压状态,血容量增加或传感器安放部位体温升高时,a3取负值的62%。即若ksd-m-0≥d6+0.10而且ksd-m-2≤d8并且kd-m-a≥c5,则a3=(c5-kd-m-a)×62/100;In normotensive state, when the blood volume increases or the body temperature of the place where the sensor is placed rises, a 3 takes 62% of the negative value. That is, if k sd-m-0 ≥d 6 +0.10 and k sd-m-2 ≤d 8 and k dma ≥c 5 , then a 3 =(c 5 -k dma )×62/100;

在血压较低或较高的状态,血容量增加或传感器安放部位体温升高时,a3取正常血压状态负值的45%。即若则a3=(c5-kd-m-a)×45/100。In the state of low or high blood pressure, when the blood volume increases or the body temperature of the place where the sensor is placed rises, a 3 takes 45% of the negative value of the normal blood pressure state. That is if or Then a 3 =(c 5 −k dma )×45/100.

第四校正变量a4Fourth correction variable a 4 :

所述步骤S4中获得的校正变量还包括第四校正变量a4,a4在外周血管扩张导致下肢血压(相对于桡动脉血压)降低的情况下,对Ts进行校正,a4的适用范围为a4>0,a4越大表明下肢血压相对于桡动脉血压降低得越多。The correction variable obtained in the step S4 also includes a fourth correction variable a 4 , a 4 corrects T s when the peripheral blood vessel dilation leads to lower extremity blood pressure (relative to the radial artery blood pressure), and the applicable range of a 4 For a 4 >0, the larger a 4 indicates that the blood pressure of the lower extremities is lowered more than the blood pressure of the radial artery.

外周血管的收缩和扩张会引起脚趾脉搏波的波峰在时间轴上的位置前后移动。若tmax-toe≥tch-toe,则否则ks-t-toe为脚趾脉搏波起始点到波峰的时间与收缩期的时间之比,200为调节系数。当波峰的最高点后移超过中点,即tmax-toe≥tch-toe时,对ks-t-toe进行校正;ks-t-toe的值较大时,提示脚趾血管扩张,下肢血压降低。即若ks-t-toe>0.8,则a4=ks-t-toe-0.8。若ks-t-toe≤0.8,a4不适用,则令a4=0。The contraction and expansion of peripheral blood vessels will cause the peak of the toe pulse wave to move back and forth on the time axis. If t max-toe ≥t ch-toe , then otherwise k st-toe is the ratio of the time from the starting point of the toe pulse wave to the peak to the time of systole, and 200 is the adjustment coefficient. When the highest point of the peak moves back beyond the midpoint, that is, when t max-toe ≥ t ch-toe , k st-toe is corrected; when the value of k st-toe is larger, it indicates that the blood vessels of the toes are dilated and the blood pressure of the lower extremities is lowered. That is, if k st-toe >0.8, then a 4 =k st-toe −0.8. If k st-toe ≤0.8 and a 4 is not applicable, set a 4 =0.

第五校正变量a5fifth correction variable a 5 ;

所述步骤S4中获得的校正变量还包括第五校正变量a5,a5的作用和性质与a4用相同,在下肢血压相对于桡动脉血压降低的情况下对Ts进行校正。The correction variable obtained in step S4 also includes a fifth correction variable a5 , the function and nature of a5 are the same as those of a4, and it corrects T s when the blood pressure of the lower extremities decreases relative to the blood pressure of the radial artery.

ks-m-toe为脚趾脉搏波收缩期平均高度与最大高度hmax-toe之比;ks-m-toe很大时表示脚趾脉搏波波峰宽阔而且平缓,提示脚趾血管扩张,相对于桡动脉而言下肢血压在降低,a5的作用和性质与a4用相同。 k sm-toe is the ratio of the average systolic height of the toe pulse wave to the maximum height h max-toe ; when k sm-toe is large, it means that the peak of the toe pulse wave is broad and gentle, indicating that the blood vessels of the toe are dilated. Compared with the radial artery, the lower extremity The blood pressure is lowering, and the function and properties of a5 are the same as that of a4.

脚趾血管没有扩张时,a5不适用。即若ks-m-toe<d9,则令a5=0。d9=0.67~0.73,优选为0.7。When the blood vessels in the toes are not dilated, a 5 is not applicable. That is, if k sm-toe <d 9 , set a 5 =0. d 9 =0.67˜0.73, preferably 0.7.

脚趾血管扩张且脉搏波波峰的最高点后移超过中点时,a5取正值。即若ks-m-toe≥d9而且ks-t-toe≥0.8,则a5=ks-m-toe-d9When the blood vessels in the toes are dilated and the highest point of the pulse wave crest moves back beyond the midpoint, a 5 takes a positive value. That is, if k sm-toe ≥d 9 and k st-toe ≥0.8, then a 5 =k sm-toe −d 9 .

脚趾血管扩张而脉搏波波峰的最高点位置没有超过中点时,a5取正值减半。即若ks-m-toe≥d9而且ks-t-toe<0.8,则a5=(ks-m-toe-d9)/2。When the blood vessels of the toes are dilated but the highest point of the pulse wave peak does not exceed the midpoint, a 5 takes a positive value and halves it. That is, if k sm-toe ≥ d 9 and k st-toe <0.8, then a 5 =(k sm-toe −d 9 )/2.

第六校正变量a6The sixth correction variable a 6 ;

所述步骤S4中获得的校正变量还包括第六校正变量a6,a6代表两个脉搏波面积的相对变化,用于脚趾血管扩张、下肢血压相对于桡动脉血压降低时对Ts进行校正。a6的适用范围为a6>0。The correction variable obtained in the step S4 also includes a sixth correction variable a 6 , a 6 represents the relative change of the two pulse wave areas, and is used to correct T s when the blood vessels of the toes are dilated and the blood pressure of the lower extremities decreases relative to the blood pressure of the radial artery . The applicable range of a 6 is a 6 >0.

ks-m-toe-ear为脚趾脉搏波收缩期的面积与耳朵脉搏波收缩期的面积之比,100为调节系数;ks-m-toe-ear与kts-toe-ear的作用和性质相同。 k sm-toe-ear is the ratio of the systolic area of the toe pulse wave to the area of the ear pulse wave systolic period, and 100 is the adjustment coefficient; the functions and properties of k sm-toe-ear and k ts-toe-ear are the same.

当脚趾波面积小于耳朵波面积,脚趾血管没有相对扩张,a6不适用。即若ks-m-toe-ear<1.0,则令a6=0。When the toe wave area is smaller than the ear wave area, the blood vessels in the toe are not relatively expanded, and a 6 is not applicable. That is, if k sm-toe-ear <1.0, set a 6 =0.

第一种先决条件下,脚趾面积大于耳朵面积很多,脚趾血管扩张较多,c6取常数1.08作为最大值备用。即若ks-m-toe-ear>1.08,则令c6=1.08。Under the first prerequisite, the area of the toes is much larger than the area of the ears, and the blood vessels of the toes expand more. The constant 1.08 of c 6 is used as the maximum value for backup. That is, if k sm-toe-ear >1.08, set c 6 =1.08.

若耳朵脉搏波形态正常,a6取最大校正值。即若ts>220而且ksd-m-0>0.88,则a6=c6-1.0。If the shape of the ear pulse wave is normal, a 6 takes the maximum correction value. That is, if t s >220 and k sd-m-0 >0.88, then a 6 =c 6 -1.0.

若耳朵脉搏波出现非常尖锐的前倾三角形或波形非常狭窄,表示耳朵脉搏波形态严重异变,此时两个脉搏波之间的相对变化被放大,需要将校准值减小来使用,a6取最大校准值的1/3。即若ts<160或ksd-m-0<0.80,则a6=(c6-1.0)×0.34。If the ear pulse wave shows a very sharp forward-leaning triangle or the waveform is very narrow, it means that the shape of the ear pulse wave is seriously abnormal. At this time, the relative change between the two pulse waves is amplified, and the calibration value needs to be reduced for use. a 6 Take 1/3 of the maximum calibration value. That is, if t s <160 or k sd-m-0 <0.80, then a 6 =(c 6 −1.0)×0.34.

耳朵脉搏波形态异变不太严重时,a6取最大校正值的2/3。即若160<ts≤220或0.80<ksd-m-0≤0.88,则a6=(c6-1.0)×0.67。When the ear pulse wave morphological changes are not too serious, a 6 takes 2/3 of the maximum correction value. That is, if 160<t s ≤220 or 0.80<k sd-m-0 ≤0.88, then a 6 =(c 6 −1.0)×0.67.

第二种先决条件下,脚趾面积大于耳朵面积,脚趾血管的相对扩张不太严重,c6取正变量备用。即若1.0≤ks-m-toe-ear≤1.08,则c6=ks-m-toe-ear-1.0。Under the second prerequisite, the area of the toes is larger than the area of the ears, and the relative expansion of blood vessels in the toes is not too serious, and c 6 takes a positive variable for use. That is, if 1.0≤k sm-toe- ear≤1.08, then c 6 =k sm-toe-ear- 1.0.

若耳朵脉搏波形态正常,a6取正变量作校正值。即若ts>220并且ksd-m-0>0.88,则a6=c6If the shape of the ear pulse wave is normal, a 6 takes a positive variable as the correction value. That is, if t s >220 and k sd-m-0 >0.88, then a 6 =c 6 .

若耳朵脉搏波形态严重异变时,脉搏波之间的相对变化被放大,需要将校准值减小来使用,a6取正变量的1/3。即若ts≤160或ksd-m-0≤0.80,则a6=c6×0.34。If the shape of the ear pulse wave changes seriously, the relative change between the pulse waves will be amplified, and the calibration value needs to be reduced for use, and a 6 takes 1/3 of the positive variable. That is, if t s ≤160 or k sd-m-0 ≤0.80, then a 6 =c 6 ×0.34.

若耳朵脉搏波不太严重的异变时,a6取正变量的2/3,即若160<ts≤220或0.80<ksd-m-0≤0.88,则a6=c6×0.67。If the ear pulse wave is not too serious, a 6 takes 2/3 of the positive variable, that is, if 160<t s ≤220 or 0.80<k sd-m-0 ≤0.88, then a 6 =c 6 ×0.67 .

第七校正变量a7the seventh correction variable a 7 ;

所述步骤S4中获得的校正变量还包括第七校正变量a7,a7的作用和性质与a6用相同,a7代表两个脉搏波收缩期宽度(收缩期时间)的相对变化。The correction variable obtained in step S4 also includes a seventh correction variable a 7 , the function and properties of a 7 are the same as those of a 6 , and a 7 represents the relative change of the systolic width (systolic time) of the two pulse waves.

kts-toe-ear为脚趾脉搏波上识别的心脏收缩期的时间与耳朵脉搏波上识别的收缩期的时间之比,825为调节系数;kts-toe-ear增大提示脚趾血管扩张,下肢血压相对于桡动脉血压在降低。 k ts-toe-ear is the ratio of the systolic time identified on the toe pulse wave to the systolic time identified on the ear pulse wave, and 825 is the adjustment coefficient; the increase of k ts-toe-ear indicates that the blood vessels in the toe are dilated, Blood pressure in the lower extremities is decreasing relative to radial blood pressure.

当脚趾血管没有相对扩张时,a7不适用。即若kts-toe-ear<1.0,则令a7=0。When the blood vessels of the toes are not relatively dilated, a 7 does not apply. That is, if k ts-toe-ear <1.0, set a 7 =0.

第一种先决条件下,当脚趾血管相对扩张较多时,c7取常数1.08作为最大值备用。即若kts-toe-ear>1.08,则令c7=1.08。Under the first prerequisite, when the blood vessels in the toe are relatively dilated, c 7 takes a constant of 1.08 as the maximum value for backup. That is, if k ts-toe-ear >1.08, set c 7 =1.08.

若耳朵脉搏波形态正常,a7取最大校正值。即若ts>220而且ksd-m-0>0.88,则a7=c7-1.0。If the shape of the ear pulse wave is normal, a 7 takes the maximum correction value. That is, if t s >220 and k sd-m-0 >0.88, then a 7 =c 7 -1.0.

若耳朵脉搏波形态严重变异时,脉搏波之间的相对变化被放大,需要将校准值减小来使用,a7取最大校正值的1/3。即若ts<160或ksd-m-0<0.80,则a7=(c7-1.0)×0.34。If the shape of the ear pulse wave changes seriously, the relative change between the pulse waves will be amplified, and the calibration value needs to be reduced for use, and a 7 takes 1/3 of the maximum correction value. That is, if t s <160 or k sd-m-0 <0.80, then a 7 =(c 7 −1.0)×0.34.

若耳朵脉搏波形态变异不太严重时,a7取最大校正值的2/3。即若160<ts≤220或0.80<ksd-m-0≤0.88,则a7=(c7-1.0)×0.67。If the ear pulse wave shape variation is not too serious, a 7 takes 2/3 of the maximum correction value. That is, if 160<t s ≤220 or 0.80<k sd-m-0 ≤0.88, then a 7 =(c 7 −1.0)×0.67.

第二种先决条件下,当脚趾宽度大于耳朵宽度,脚趾血管的相对扩张不太严重,c7取正变量备用。即若1.0≤kts-toe-ear≤1.08,则c7=kts-toe-ear-1.0。Under the second prerequisite, when the width of the toe is greater than the width of the ear, the relative expansion of the blood vessels of the toe is not too serious, and c 7 takes a positive variable for use. That is, if 1.0≤k ts-toe- ear≤1.08, then c 7 =k ts-toe-ear- 1.0.

若耳朵脉搏波形态正常,a7取正变量作校正值。即若ts>220并且ksd-m-0>0.88,则a7=c7If the shape of the ear pulse wave is normal, a 7 takes a positive variable as the correction value. That is, if t s >220 and k sd-m-0 >0.88, then a 7 =c 7 .

若耳朵脉搏波形态严重变异,a7取正变量的1/3。即若ts≤160或ksd-m-0≤0.80,则a7=c7×0.34。If the shape of the ear pulse wave varies seriously, a 7 takes 1/3 of the positive variable. That is, if t s ≤160 or k sd-m-0 ≤0.80, then a 7 =c 7 ×0.34.

若耳朵脉搏波形态的变异不太严重,a7取正变量的2/3。即若160<ts≤220或0.80<ksd-m-0≤0.88,则a7=c7×0.67。If the variation of the ear pulse wave shape is not too serious, a 7 takes 2/3 of the positive variable. That is, if 160<t s ≤220 or 0.80<k sd-m-0 ≤0.88, then a 7 =c 7 ×0.67.

所述步骤S5中的校正矩阵其中若有ai=0表示该ai不适用。所述步骤S6具体为:连续获取8个心动周期下的校正矩阵,用8个心动周期的变量的平均值来克服呼吸波动的干扰,8个变量采用递推方式选取,每计算出一个最新变量就淘汰一个最老变量。校正方法为:Tsma=Tsm(1-Am);其中,Ai为第i个心动周期下的校正矩阵,Tsi为第i个心动周期下的TsCorrection matrix in the step S5 Wherein, if a i =0, it means that a i is not applicable. The step S6 is specifically: continuously obtain the correction matrix under 8 cardiac cycles, use the average value of the variables of the 8 cardiac cycles to overcome the interference of respiratory fluctuations, select the 8 variables in a recursive manner, and calculate a newest variable every time Just eliminate the oldest variable. The correction method is: T sma =T sm (1-A m ); where, A i is the correction matrix in the i-th cardiac cycle, and T si is the T s in the i-th cardiac cycle.

最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围,其均应涵盖在本发明的权利要求和说明书的范围当中。Finally, it should be noted that: the above embodiments are only used to illustrate the technical solutions of the present invention, rather than limiting them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: It is still possible to modify the technical solutions described in the foregoing embodiments, or perform equivalent replacements for some or all of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the technical solutions of the various embodiments of the present invention. All of them should be covered by the scope of the claims and description of the present invention.

Claims (10)

1. A method for correcting the pulse wave propagation time related to the systolic pressure, characterized by comprising the steps of:
s1) detecting the pulse wave at the ear in real time in each cardiac cycle and analyzing to obtain the following data of the ear pulse wave: height h of aortic valve closing point on ear pulse wavesdTime t of contraction of ear pulse wavesIn milliseconds, the diastolic time t of the ear pulse wavedIn milliseconds, the maximum height h of the ear pulse wavemax
S2) detecting each heart in real timePulse waves at toes under the action cycle are analyzed to obtain the following data of the toe pulse waves: systolic time t of toe pulse waves-toeIn milliseconds, the diastolic time t of the toe pulse waved-toeIn milliseconds, the maximum height h of the pulse wave of the toesmax-toeTime t from the starting point of the toe pulse wave to the midpoint of the peakch-toeUnit is millisecond, and time t from starting point of toe pulse wave to peak of peakmax-toeIn milliseconds; the middle point of the wave crest refers to the middle point of the turning point of the rising edge and the turning point of the falling edge at the wave crest;
s3) calculating a pulse wave propagation time T associated with the systolic pressuresSaid T issThe time difference from the closing point of the aortic valve on the ear pulse wave to the closing point of the aortic valve on the toe pulse wave is defined; h is the amplitude of the ear pulse wave or the toe pulse wave in the direction of the longitudinal axis;
s4) calculating correction variables in the cardiac cycle by using the data obtained in the steps S1 and S2 in the same cardiac cycle;
s5) according to the correction variable under the cardiac cycle obtained in the step S4, calculating to obtain a correction matrix under the cardiac cycle;
s6) obtaining correction matrices for a plurality of cardiac cycles in succession, for the T obtained through step S3sCarrying out correction; .
2. The method for correcting systolic pressure-related pulse wave propagation time according to claim 1, characterized in that the correction matrix in step S5aiIs the ith of the correcting variables.
3. The method for correcting systolic pressure-related pulse wave propagation time according to claim 1, characterized in that said step S6 specifically includes: continuously acquiring correction matrixes under 8 cardiac cycles; the correction method comprises the following steps: t issma=Tsm(1-Am) (ii) a Wherein,Aifor the correction matrix at the i-th cardiac cycle, TsiIs T at the ith cardiac cycles
4. Method for correcting the pulse wave propagation time related to systolic pressure according to claim 1, characterised in that the first correcting variable a1Calculated by the following formula:
if d is1≤ksd-m-0≤d1-2Then a is1=(d1-2-ksd-m-0)×0.50;
If k issd-m-0<d1Then a is1=28×0.50;
If k issd-m-0>d1-2Then a is1=0;
Wherein,d1=76~84,d1-2=104~112。
5. method for correcting the pulse wave propagation time related to systolic pressure according to claim 1, characterised in that the second correcting variable a2Calculated by the following formula:
if k issd-m>(d2+ (age-14)/15/100), then a2=ksd-m-(d2+(age-14)/15/100);
If k issd-m≤(d2+ (age-14)/15/100), then a2=0;
Wherein if ksd-m-0-ksd-m-ts| ≧ 40 and (k)sd-m-0+ksd-m-ts)/2≥ksd-m-2Then k issd-m=2×ksd-m-2-(ksd-m-0+ksd-m-ts) /2, otherwise ksd-m=ksd-m-2
age is age, d2=1.17~1.27。
6. Method for correcting the pulse wave propagation time related to systolic pressure according to claim 1, characterised in that the third correcting variable a3Calculated by the following formula:
if c is4<kd-m-a<c5Then a is3=0;
If k issd-m-0<d6Or ksd-m-2>d7Then a is3=0;
If k issd-m-0≥d6+0.10 and ksd-m-2≤d8And k isd-m-a≤c4Then a is3=(c4-kd-m-a)×67/100;
If it isOrThen a3=(c4-kd-m-a)×50/100;
If k issd-m-0≥d6+0.10 and ksd-m-2≤d8And k isd-m-a≥c5Then a is3=(c5-kd-m-a)×62/100;
If it isOrThen a3=(c5-kd-m-a)×45/100;
Wherein if ksd-m-0-ksd-m-ts| ≧ 40 and (k)sd-m-0+ksd-m-ts)/2≥ksd-m-2And k issd-m-ts≥d3-2Then, thenOtherwise
If k issd-m-ts≤d3-2Then, thenIf it isThenIf it isThen c4=(d4+(age-14)/8)/100,d4=23~35,c5=(d5+(age-14)/8)/100,d5=27~39,d6=0.97~1.03,d7=1.52~1.58,d8=1.42~1.48,d3-2=1.21~1.31,d3Age is 0.02-0.14, age is age.
7. Method for correcting the pulse wave propagation time related to systolic pressure according to claim 1, characterised in that the fourth correcting variable a4Calculated by the following formula: if k iss-t-toe>0.8, then a4=ks-t-toe-0.8;
If k iss-t-toe≤0.8, then a4=0;
Wherein if tmax-toe≥tch-toeThen, thenOtherwise
8. Method for correcting the pulse wave propagation time in relation to systolic pressure according to claim 1, characterised in that the fifth correcting variable a5Calculated by the following formula:
if k iss-m-toe<d9Then a is5=0;
If k iss-m-toe≥d9And k iss-t-toeA is more than or equal to 0.85=ks-m-toe-d9
If k iss-m-toe≥d9And k iss-t-toe<0.8, then a5=(ks-m-toe-d9)/2;
Wherein d is9=0.67~0.73,
9. Method for correcting the pulse wave propagation time in relation to systolic pressure according to claim 1, characterised in that the sixth correcting variable a6Calculated by the following formula:
if k iss-m-toe-ear<1.0, then a6=0;
When k iss-m-toe-ear>1.08, then c6When t is equal to 1.08, the product iss>220 and k issd-m-0>0.88, then a6=c61.0, if ts<160 or ksd-m-0<0.80, then a6=(c6-1.0) × 0.34.34, if 160<tsLess than or equal to 220 or 0.80<ksd-m-0A is less than or equal to 0.88, then a6=(c6-1.0)×0.67;
When k is more than or equal to 1.0s-m-toe-earC is less than or equal to 1.08, then6=ks-m-toe-ear-1.0, when t iss>220 and k issd-m-0>0.88, then a6=c6If t iss160 or k or lesssd-m-0A is less than or equal to 0.80, then a6=c6× 0.34.34, 160, if<tsLess than or equal to 220 or 0.80<ksd-m-0A is less than or equal to 0.88, then a6=c6×0.67;
Wherein,
10. method for correcting the pulse wave propagation time in relation to systolic pressure according to claim 1, characterised in that the seventh correcting variable a7Calculated by the following formula:
if k ists-toe-ear<1.0, then a7=0;
When k ists-toe-ear>1.08, then c7When t is equal to 1.08, the product iss>220 and k issd-m-0>0.88, then a7=c71.0, if ts<160 or ksd-m-0<0.80, then a7=(c7-1.0) × 0.34.34, if 160<tsLess than or equal to 220 or 0.80<ksd-m-0A is less than or equal to 0.88, then a7=(c7-1.0)×0.67;
When k is more than or equal to 1.0ts-toe-earC is less than or equal to 1.08, then7=kts-toe-ear-1.0, in this case, if ts>220 and ksd-m-0>0.88, then a7=c7If t iss160 or k or lesssd-m-0A is less than or equal to 0.80, then a7=c7× 0.34.34, 160, if<tsLess than or equal to 220 or 0.80<ksd-m-0A is less than or equal to 0.88, then a7=c7×0.67;
Wherein,
CN201611045054.5A 2016-11-22 2016-11-22 The bearing calibration of the pulse wave propagation time related to systolic pressure Active CN106580303B (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CN201611045054.5A CN106580303B (en) 2016-11-22 2016-11-22 The bearing calibration of the pulse wave propagation time related to systolic pressure
PCT/CN2017/098155 WO2018095083A1 (en) 2016-11-22 2017-08-18 Pulse wave propagation time correction method
JP2019541843A JP6736110B2 (en) 2016-11-22 2017-11-20 Method of correcting pulse wave transit time for arterial blood pressure
PCT/CN2017/111799 WO2018095291A1 (en) 2016-11-22 2017-11-20 Correction method for pulse wave propagation time related to diastolic blood pressure and systolic blood pressure
EP17874481.9A EP3545832B1 (en) 2016-11-22 2017-11-20 Correction method for pulse wave propagation time related to diastolic blood pressure and systolic blood pressure
US16/391,287 US20190246919A1 (en) 2016-11-22 2019-04-22 Method and system for correcting pulse transit time associated with arterial blood pressure or blood pressure value calculated by pulse transit time
US17/874,618 US20220378307A1 (en) 2016-11-22 2022-07-27 Method for correcting pulse wavetransit time associated with diastolic blood pressure or systolic blood pressure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611045054.5A CN106580303B (en) 2016-11-22 2016-11-22 The bearing calibration of the pulse wave propagation time related to systolic pressure

Publications (2)

Publication Number Publication Date
CN106580303A true CN106580303A (en) 2017-04-26
CN106580303B CN106580303B (en) 2018-03-06

Family

ID=58592985

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611045054.5A Active CN106580303B (en) 2016-11-22 2016-11-22 The bearing calibration of the pulse wave propagation time related to systolic pressure

Country Status (1)

Country Link
CN (1) CN106580303B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018095291A1 (en) * 2016-11-22 2018-05-31 浙江脉联医疗设备有限公司 Correction method for pulse wave propagation time related to diastolic blood pressure and systolic blood pressure
CN108784676A (en) * 2018-06-20 2018-11-13 博动医学影像科技(上海)有限公司 The method and device of pressure difference is obtained based on age information
CN108523867B (en) * 2018-03-28 2020-12-29 武汉麦咚健康科技有限公司 Self-calibration PPG non-invasive blood pressure measurement method and system

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0443267A1 (en) * 1990-02-23 1991-08-28 Sentinel Monitoring, Inc. Method and apparatus for continuous non-invasive blood pressure monitoring
CN102008296A (en) * 2010-12-24 2011-04-13 吉林大学 Device and method for measuring arterial blood pressures based on pulse wave signals and electrocardiosignals
CN102258364A (en) * 2010-05-31 2011-11-30 深圳市盛力康实业发展有限公司 Pulse wave identification method, system and artery function detection instrument
CN103385702A (en) * 2013-07-26 2013-11-13 中国科学院深圳先进技术研究院 Non-invasive blood pressure continuous detection device and method
CN104382571A (en) * 2014-10-28 2015-03-04 李久朝 Method and device for measuring blood pressure upon radial artery pulse wave conduction time

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0443267A1 (en) * 1990-02-23 1991-08-28 Sentinel Monitoring, Inc. Method and apparatus for continuous non-invasive blood pressure monitoring
CN102258364A (en) * 2010-05-31 2011-11-30 深圳市盛力康实业发展有限公司 Pulse wave identification method, system and artery function detection instrument
CN102008296A (en) * 2010-12-24 2011-04-13 吉林大学 Device and method for measuring arterial blood pressures based on pulse wave signals and electrocardiosignals
CN103385702A (en) * 2013-07-26 2013-11-13 中国科学院深圳先进技术研究院 Non-invasive blood pressure continuous detection device and method
CN104382571A (en) * 2014-10-28 2015-03-04 李久朝 Method and device for measuring blood pressure upon radial artery pulse wave conduction time

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018095291A1 (en) * 2016-11-22 2018-05-31 浙江脉联医疗设备有限公司 Correction method for pulse wave propagation time related to diastolic blood pressure and systolic blood pressure
WO2018095083A1 (en) * 2016-11-22 2018-05-31 浙江脉联医疗设备有限公司 Pulse wave propagation time correction method
CN108523867B (en) * 2018-03-28 2020-12-29 武汉麦咚健康科技有限公司 Self-calibration PPG non-invasive blood pressure measurement method and system
CN108784676A (en) * 2018-06-20 2018-11-13 博动医学影像科技(上海)有限公司 The method and device of pressure difference is obtained based on age information

Also Published As

Publication number Publication date
CN106580303B (en) 2018-03-06

Similar Documents

Publication Publication Date Title
EP3545832B1 (en) Correction method for pulse wave propagation time related to diastolic blood pressure and systolic blood pressure
CN107106055B (en) Method for improving blood pressure measurement efficiency and blood pressure measurement device
CN107233087A (en) A kind of Woundless blood pressure measuring device based on photoplethysmographic feature
US20120157791A1 (en) Adaptive time domain filtering for improved blood pressure estimation
CN106618504A (en) High-accuracy continuous non-invasive blood pressure measuring device with self-adaptation calibration function
CN113470805A (en) Method for establishing blood pressure model
EP4534017B1 (en) Doppler ultrasound-based continuous blood pressure measuring apparatus and electronic device
EP4422482B1 (en) Device, system and method for calibrating a blood pressure surrogate for use in monitoring a subject&#39;s blood pressure
KR20190048878A (en) Method and apparatus for measuring blood pressure using optical sensor
WO2017199174A1 (en) Non-invasive system and method for measuring blood pressure variability
US7887491B2 (en) Impedance based device for non-invasive measurement of blood pressure and ankle-brachial index
CN106580303B (en) The bearing calibration of the pulse wave propagation time related to systolic pressure
CN103393415B (en) The measuring method of continuous blood pressure change
US20230355116A1 (en) Arterial-pressure estimation apparatus, arterial-pressure estimation system, and arterial-pressure estimation method
CN117064354A (en) Cuffless continuous blood pressure measurement method and system
JP2024540010A (en) DEVICE, SYSTEM, AND METHOD FOR CALIBRATING A BLOOD PRESSURE SURROGATE FOR USE IN MONITORING A SUBJECT&#39;S BLOOD PRESSURE - Patent application
US8409105B2 (en) Device for non-invasive measurement of blood pressure and ankle-brachial index
CN106377238B (en) The bearing calibration of the pulse wave propagation time related to diastolic pressure
TWI733378B (en) Method of establishing blood pressure model
Kim et al. A new blood pressure measurement using dual-cuffs
Kaushik et al. A comprehensive study on blood pressure measurement techniques
Park et al. Cuffless and noninvasive tonometry mean arterial pressure measurement by physiological characteristics and applied pressure
US20220378307A1 (en) Method for correcting pulse wavetransit time associated with diastolic blood pressure or systolic blood pressure
Yan et al. Study on the variability of pulse wave and ECG of graduate students with different body positions
US20230293035A1 (en) Cardiac Cycle Analysis Method and System

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20250908

Address after: 400000 Chongqing Nanan District Economic Development Zone Yinglong Town Meijia Road No. 1 Building 3 (Industrial Factory) 5th Floor

Patentee after: Mailian (Chongqing) Medical Technology Co.,Ltd.

Country or region after: China

Address before: 401G, No. 22, Xinyan Road, Economic and Technological Development Zone, Yuhang District, Hangzhou City, Zhejiang Province, 310000

Patentee before: ZHEJIANG MAILIAN MEDICAL EQUIPMENT Co.,Ltd.

Country or region before: China